Sumitovant Buys Myovant
Sumitovant has acquired all outstanding shares of Myovant not already owned by Sumitovant in an all-cash deal valued at $1.7 billion.
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
